Marianne Pavel
玛丽安·帕维尔
MD, PhD
Professor of Endocrinology; Head of NET Program内分泌学教授；神经内分泌肿瘤项目负责人
👥Biography 个人简介
Prof. Marianne Pavel is a world-renowned NET specialist at Charité Berlin, leading European clinical research in PRRT and targeted therapies. She has chaired major international guideline panels (ENETS) and contributed seminal trials on everolimus and somatostatin analogues in gastroenteropancreatic NETs.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
European NET Guidelines Leadership
Chaired and contributed to European Neuroendocrine Tumor Society (ENETS) consensus guidelines on treatment of gastroenteropancreatic NETs, establishing evidence-based standards across Europe.
PRRT and Targeted Therapy Trials
Led and participated in pivotal PRRT and everolimus trials in Europe, including RADIANT studies, advancing therapeutic options for advanced NET patients.
Representative Works 代表性著作
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours (RADIANT-2)
Lancet (2011)
Key phase III trial evaluating everolimus combined with octreotide LAR in carcinoid tumors, informing combination treatment strategies.
ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial NETs
Neuroendocrinology (2016)
Authoritative European guideline update synthesizing evidence on systemic therapy, PRRT, and multidisciplinary management of metastatic NET.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
James Yao
MD Anderson Cancer Center
Matthew Kulke
Boston Medical Center / Boston University
Emily Bergsland
University of California, San Francisco (UCSF)
Eric Liu
Rocky Mountain Cancer Centers
关注 玛丽安·帕维尔 的研究动态
Follow Marianne Pavel's research updates
留下邮箱，当我们发布与 Marianne Pavel（Charité – Universitätsmedizin Berlin）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment